Stents with dual tissue-wall anchoring features

US10779967B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10779967-B2
Application numberUS-201815939410-A
CountryUS
Kind codeB2
Filing dateMar 29, 2018
Priority dateMar 30, 2017
Publication dateSep 22, 2020
Grant dateSep 22, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates generally to the field of stents for body lumen drainage. In particular, the present disclosure relates to systems and methods for forming a fluid channel between tissue walls of varying thickness using a stent.

First claim

Opening claim text (preview).

What is claimed is: 1. A stent, comprising: a stent body formed of a woven filament having a constrained configuration, the stent body having an expanded configuration with a proximal portion of the body expanded into a proximal retention member, a distal portion expanded into a distal retention member, and a cylindrical saddle region extending between the proximal and distal retention members; wherein the proximal retention member, distal retention member and cylindrical saddle region define an open interior passage configured to permit flow therethrough; and wherein the proximal retention member includes first and second flanges separated from each other by a first distance, and the distal retention member includes third and fourth flanges separated from each other by a second distance, the first distance being greater than the second distance; wherein the first, second, third, and fourth flanges are the same shape. 2. The stent of claim 1 , wherein the second and third flanges are separated by a third distance, the third distance being greater than the first distance. 3. The stent of claim 1 , wherein the first, second, third and fourth flanges comprise planar surfaces extending perpendicular to a circumference of the stent body. 4. The stent of claim 1 , wherein a diameter of the first, second, third and fourth flanges is larger than a diameter of the cylindrical saddle region. 5. The stent of claim 1 , wherein the first and second flanges are configured to contact opposite sides of a first tissue layer, and the third and fourth flanges are configured to contact opposite sides of a second tissue layer. 6. The stent of claim 1 , further comprising a valve disposed within the open interior passage of the stent body. 7. A stent, comprising: an elongate body having a constrained configuration, the elongate body having an expanded configuration with a proximal portion of the body expanded into a proximal retention member, a distal portion expanded into a distal retention member, and a cylindrical saddle region extending between the proximal and distal retention members; the proximal and distal retention members formed of a woven material and the cylindrical saddle region formed of a knitted material; wherein the proximal retention member, distal retention member and cylindrical saddle region define an open interior passage configured to permit flow therethrough; and wherein the proximal retention member includes first and second flanges separated from each other by a first distance, and the distal retention member includes third and fourth flanges separated from each other by a second distance, the first distance being greater than the second distance; wherein the first, second, third, and fourth flanges are the same shape. 8. The stent of claim 7 , wherein the second and third flanges are separated by a third distance, the third distance being greater than the first distance. 9. The stent of claim 7 , wherein the first, second, third and fourth flanges comprise planar surfaces extending perpendicular to a circumference of the elongate body. 10. The stent of claim 7 , wherein a diameter of the first, second, third and fourth flanges is larger than a diameter of the cylindrical saddle region. 11. The stent of claim 7 , wherein the first and second flanges are configured to contact opposite sides of a first tissue layer, and the third and fourth flanges are configured to contact opposite sides of a second tissue layer. 12. The stent of claim 7 , further comprising a valve disposed within the open interior passage of the elongate body. 13. A stent, comprising: an elongate body having a constrained configuration, the elongate body having an expanded configuration with a proximal portion of the body expanded into a proximal retention member, a distal portion expanded into a distal retention member, and a cylindrical saddle region extending between the proximal and distal flanges; the proximal and distal retention members formed of a woven material and the cylindrical saddle region formed of a polymeric material; wherein the proximal retention member, distal retention member and cylindrical saddle region define an open interior passage configured to permit flow therethrough; and wherein the proximal retention member includes first and second flanges separated from each other by a first distance, and the distal retention member includes third and fourth flanges separated from each other by a second distance, the first distance being greater than the second distance; wherein the first, second, third, and fourth flanges are the same shape. 14. The stent of claim 13 , wherein the second and third flanges are separated by a third distance, the third distance being greater than the first distance. 15. The stent of claim 13 , wherein the first, second, third and fourth flanges comprise planar surfaces extending perpendicular to a circumference of the elongate body. 16. The stent of claim 13 , wherein a diameter of the first, second, third and fourth flanges is larger than a diameter of the cylindrical saddle region. 17. The stent of claim 13 , wherein the first and second flanges are configured to contact opposite sides of a first tissue layer, and the third and fourth flanges are configured to contact opposite sides of a second tissue layer. 18. The stent of claim 13 , further comprising a valve disposed within the open interior passage of the stent body. 19. The stent of claim 13 , wherein the cylindrical saddle region includes an internal or external support structure. 20. The stent of claim 13 , wherein the cylindrical saddle region includes one or more corrugated portions.

Assignees

Inventors

Classifications

  • Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials · CPC title

  • Flowable or injectable implant compositions · CPC title

  • Growth factors · CPC title

  • Gall; Bile · CPC title

  • Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10779967B2 cover?
The present disclosure relates generally to the field of stents for body lumen drainage. In particular, the present disclosure relates to systems and methods for forming a fluid channel between tissue walls of varying thickness using a stent.
Who is the assignee on this patent?
Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/848. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).